Seenu Hariprasad to Wet Macular Degeneration
This is a "connection" page, showing publications Seenu Hariprasad has written about Wet Macular Degeneration.
Connection Strength
2.136
-
Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure. Indian J Ophthalmol. 2016 Sep; 64(9):643-647.
Score: 0.533
-
Current concepts in managing wet AMD suboptimally responsive to anti-VEGF therapy. Ophthalmic Surg Lasers Imaging Retina. 2013 May-Jun; 44(3):225-6.
Score: 0.423
-
Review of ranibizumab trials for neovascular age-related macular degeneration. Semin Ophthalmol. 2011 Nov; 26(6):372-9.
Score: 0.381
-
ASSOCIATION OF METFORMIN USE WITH RISK OF NEWLY ONSET NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEVELOPMENT. Retina. 2024 02 01; 44(2):205-213.
Score: 0.223
-
Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System. Ophthalmic Surg Lasers Imaging Retina. 2018 12 01; 49(12):913-917.
Score: 0.156
-
Use of Optical Coherence Tomography Angiography in Masqueraders of Wet Age-Related Macular Degeneration and Choroidal Neovascularization. Ophthalmic Surg Lasers Imaging Retina. 2018 02 01; 49(2):80-85.
Score: 0.147
-
Treatment Burden in Neovascular AMD:Visual Acuity Outcomes are Associated With Anti-VEGF Injection Frequency. Ophthalmic Surg Lasers Imaging Retina. 2017 10 01; 48(10):780-784.
Score: 0.144
-
Effect of Fluid Status at Week 12 on Visual and Anatomic Outcomes at Week 52 in the VIEW 1 and 2 Trials. Ophthalmic Surg Lasers Imaging Retina. 2016 Mar; 47(3):238-44.
Score: 0.129